Back to results
CompletedPhase 3

WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes

NCT00147758

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Birmingham, Alabama, United States

+46 additional locations

View on ClinicalTrials.gov
WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes — TrialFind